TY - JOUR
T1 - Understanding the pathophysiology of premature ejaculation
T2 - Bridging the link between pharmacological and psychological interventions
AU - Yusof, Farid
AU - Sidi, Hatta
AU - Das, Srijit
AU - Midin, Marhani
AU - Kumar, Jaya
AU - Hatta, Muhammd Hizri
N1 - Funding Information:
The authors acknowledge the financial support by UKM (DLP-2014-009) and thank Dr. Nik Ruzyanei Nik Jaafar from the Department of Psychiatry for editing the manuscript.
Publisher Copyright:
© 2018 Bentham Science Publishers.
PY - 2018
Y1 - 2018
N2 - Premature ejaculation (PE) is one of the commonest male sexual dysfunctions. It is characterized by ejaculation which occurs before or soon after vaginal penetration, which causes significant psychological distress to the individual, and his partner. The exact cause of PE is still unknown but several mechanisms are proposed, and these involve complex interactions of neurophysiological, psychosocial, and cognitive factors. We discuss the role of serotonin, nitric oxide, phosphodiesterase enzymes and other neurotransmitters. Treatment of PE tends to co-occur with other sexual difficulties, especially erectile dysfunction (ED). Treatment with selective serotonin reuptake inhibitors (SSRIs) and Dapoxitene are also discussed in detail. The treatment strategy requires a comprehensive holistic approach incorporating both combination of psychopharmacological agent and cognitive-behavioral therapy (CBT). The present review highlights the integration of the hypothalamic-neural and reverberating emotional circuit and discusses the etiology and treatment for patients with PE.
AB - Premature ejaculation (PE) is one of the commonest male sexual dysfunctions. It is characterized by ejaculation which occurs before or soon after vaginal penetration, which causes significant psychological distress to the individual, and his partner. The exact cause of PE is still unknown but several mechanisms are proposed, and these involve complex interactions of neurophysiological, psychosocial, and cognitive factors. We discuss the role of serotonin, nitric oxide, phosphodiesterase enzymes and other neurotransmitters. Treatment of PE tends to co-occur with other sexual difficulties, especially erectile dysfunction (ED). Treatment with selective serotonin reuptake inhibitors (SSRIs) and Dapoxitene are also discussed in detail. The treatment strategy requires a comprehensive holistic approach incorporating both combination of psychopharmacological agent and cognitive-behavioral therapy (CBT). The present review highlights the integration of the hypothalamic-neural and reverberating emotional circuit and discusses the etiology and treatment for patients with PE.
KW - Cognitive behaviour therapy
KW - Dopexetine
KW - Erectile dysfunction
KW - Pathophysiology
KW - Premature ejaculation
KW - SSRIs
UR - http://www.scopus.com/inward/record.url?scp=85048945978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048945978&partnerID=8YFLogxK
U2 - 10.2174/1389450117666161215161108
DO - 10.2174/1389450117666161215161108
M3 - Review article
C2 - 27993112
AN - SCOPUS:85048945978
SN - 1389-4501
VL - 19
SP - 856
EP - 864
JO - Current Drug Targets
JF - Current Drug Targets
IS - 8
ER -